avatrombopag

Italy

Drugs containing this active substance

  • DOPTELET

    It is used in adults with chronic liver disease to treat low platelet counts before a medical procedure with a risk of bleeding. It is also indicated for treating adults with primary chronic immune thrombocytopenia (ITP) when other treatments have not been sufficient.

    Form: tablets, film-coated

    Active substance Dosage
    avatrombopag -

    ATC: B02BX08

    Manufacturer: SWEDISH ORPHAN BIOVITRUM AB (PUBL)